Infectious Disease

Researches seeking to eliminate HIV are close enough to see the finish line, but with no idea how far away they are from a cure.

Foreign-born black women aren’t benefiting from HIV prevention programs at the same rates as other women.

The overuse of antimicrobials is associated with antimicrobial resistance, which is now a global crisis.

New research underscores the value of review by an ID physician, nurse, or pharmacist before starting OPAT.

The product has an estimated market size of $338M for the 12 months ending August 2018 according to IQVIA.

Stigma may cause undiagnosed individuals with HIV to go unidentified and fail to get quality care and treatment.

FDA officials have approved omadacycline (Nuzyra, Paratek), a modernized tetracycline, to treat adults with acute skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

Inconsistency of insurance policy coverage, unaffordability, and difficulty accessing vaccine providers were found to be key barriers for adult immunization in a recent study by UCLA Center for Health Policy researchers.

Financial modeling tool shows research and development lacking of new vaccine candidates for HIV, tuberculosis, and malaria.

Community-acquired pneumonia is a common infection and a leading cause of morbidity and mortality worldwide.

Watch as our Executive Vice President for Pharmacy Advocacy discusses pharmacy roles in immunizations, and record his "word of the day" for a chance to win $1000 gift card!

Staying up to date with vaccinations is crucial in preventing children and their classmates from getting sick.

Although it can lead to death, PCP is preventable with appropriate prophylaxis therapy given to patients at high risk of infection.

Approval for tafenoquine was granted based on the efficacy and safety data gleaned from a comprehensive global clinical development program for P vivax prevention of relapse,

Antimicrobial stewardship programs (ASPs) are often tasked with addressing a wide scope of antimicrobial misuse with limited resources.

Testing for respiratory syncytial virus (RSV) infection during the influenza season is uncommon among pregnant mothers.

Top news of the day from across the health care landscape

An extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae (K pneumoniae) that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.

The 2017-2018 flu season was severe, resulting in 172 pediatric deaths across the country.

The results of a new analysis have revealed that incidence of intensive care unit bacteremia is decreasing over time.

Individuals who inject drugs are at an increased risk of developing invasive methicillin-resistant Staphylococcus aureus (MRSA).

Point-of-care testing (POTC) increase patients' access to care and treatment. In 2 areas—influenza and streptococcal pharyngitis—POCT is available, but not used as often as it could be.

Levofloxacin is a fluoroquinolone antibiotic medicine that treats certain bacterial infections, including some types of pneumonia and bronchitis.